InvestorsHub Logo
Followers 17
Posts 1064
Boards Moderated 0
Alias Born 07/20/2010

Re: None

Thursday, 05/26/2016 11:37:30 AM

Thursday, May 26, 2016 11:37:30 AM

Post# of 2500
$CRMD Recent News Filing

Great PR from AccessWire
CorMedix Inc. Presented Post-Market Clinical Utility Data from Neutrolin(R) Usage Monitoring Program at 53rd Joint Congress of the European Renal Association - European Dialysis and Transplant Association.

Check it out:

"These data demonstrated that use of Neutrolin is associated with 96.0% reduction in the rate of CRBSI and 96.7% reduction in thrombosis compared to published historical benchmarks of 3.5 CRBSIs and 2-3 episodes of thrombosis per 1,000 catheter days. No significant adverse drug reactions that led to the discontinuation of Neutrolin use were reported."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRMD News